Category: BioUtah News

PolarityTE Announces First Subject Enrolled in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers

Posted on by Press Release

SALT LAKE CITY, May 3, 2022 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: PTE) today announced the enrollment of the first subject in the Phase III pivotal study evaluating SkinTE in the investigational use of treatment of Wagner grade 2 diabetic foot ulcers (DFUs), entitled “Closure Obtained with Vascularized Epithelial Regeneration for DFUs with SkinTE,” or “COVER […]

Read More

BioUtah Remembers Senator Orrin Hatch

Posted on by admin

Senator Orrin Hatch, who served 42 years in the Senate and is the longest serving Senator in Utah’s history, died at 88 last Saturday. He is remembered fondly by Utah’s life sciences industry as a stalwart champion for medical innovation and improving the lives of patients. Reflecting on the Senator’s life and legacy, Kelvyn Cullimore, […]

Read More

Merit Medical Receives FDA “Breakthrough Device Designation” for Embosphere® Microspheres for Use in Genicular Artery Embolization for Symptomatic Knee Osteoarthritis

Posted on by Press Release

SOUTH JORDAN, Utah, March 07, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), announced today that it has received “breakthrough device designation” from the U.S. Food & Drug Administration (FDA) for Embosphere® Microspheres for the Genicular Artery Embolization (GAE) indication. GAE is a procedure intended to reduce pain and disability caused by knee osteoarthritis by […]

Read More